Clinical validation and application of high-throughput novel coronavirus (2019-nCoV) screening detection kit

Clinical validation and application of high-throughput novel coronavirus (2019-ncov) screening detection kit

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000030833

Enrollment

Unknown

Registered

2020-03-15

Start date

2020-03-22

Completion date

Unknown

Last updated

2020-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Gold Standard:PCR Nucleic acid detection

Index test:high-throughput&#32

novel&#32

coronavirus&#32

(2019-nCoV)&#32

screening&#32

detection&#32

kit

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Patients with novel coronavirus pneumonia and suspending patients

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
RNA of 2019-nCov;SPE, SEN, ACC, AUC of ROC;	—

Countries

China

Contacts

Public ContactNing Qin

Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology

qning@vip.sina.com+86 027-83662391

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026